John Gerich
-
- Diabetes Treatment and Management 6
- Diabetes Management and Research 6
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Surgery top 5%
- Pancreatic function and diabetes 4
- Genetics top 5%
- Diabetes and associated disorders 2
- Pharmacology top 5%
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer 5
-
- Neuroblastoma Research and Treatments 1
-
- Adipose Tissue and Metabolism 1
- Co-authors
- Matthew C. RiddleJulio RosenstockAsimina MitrakouMichael StümvollTrond JenssenWalkyria de Paula PimentaTheo van HaeftenH Yki-Järvinen
- Journals
- Hormone and Metabolic Research (3 papers)Diabetes Care (3 papers)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
John Gerich
11 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 2.5k
- Surgery 937
- Genetics 512
- Pharmacology 281
- Molecular Biology 941
Countries citing papers authored by John Gerich
This map shows the geographic impact of John Gerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gerich more than expected).
Fields of papers citing papers by John Gerich
This network shows the impact of papers produced by John Gerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gerich. The network helps show where John Gerich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Gerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 89 | |
| 2 | Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)breakdown → | 2009 | 707 |
| 3 | 2006 | 34 | |
| 4 | The Treat-to-Target Trialbreakdown → | 2003 | 1154 |
| 5 | 2001 | 25 | |
| 6 | Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.breakdown → | 2000 | 826 |
| 7 | 1998 | 46 | |
| 8 | 1996 | 31 | |
| 9 | 1993 | 144 | |
| 10 | 1980 | 3 | |
| 11 | 1977 | 21 |
About John Gerich
John Gerich is a scholar working on Endocrinology, Diabetes and Metabolism, Complementary and alternative medicine and Surgery, having authored 11 papers that have together received 3.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (4 papers), Diabetes and associated disorders (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Neuroblastoma Research and Treatments (1 paper) and Adipose Tissue and Metabolism (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Surgery (937 citations) and Genetics (512 citations). John Gerich has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Matthew C. Riddle, Julio Rosenstock, Asimina Mitrakou, Michael Stümvoll, Trond Jenssen, Walkyria de Paula Pimenta, Theo van Haeften, H Yki-Järvinen, W. Renn and Lawrence Blonde. Their work appears in journals such as Hormone and Metabolic Research, Diabetes Care, Clinical Therapeutics, Transplantation and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.